Reports from Acting President & Interim Chief Scientific Officer.
Consideration of update from IP Task Force and proposal to modify the payback requirement for products licensed by for-profit entities.
Report from and possible consideration of study of proposal from the California State University system.
Consideration of Standards Working Group items from 7/27/07 meeting including:
a. Use of cell lines derived under Japanese Guidelines for Derivation and Utilization of Human Embryonic
b. Limitations on payment for cells; and
c. Requirements for use of somatic cells and human tissue
Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).
Public report of any action taken, if necessary, during closed session.
Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.
The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at email@example.com or 415-396-9100.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.